Trading Update
Science Group's trading update for the nine months ended September 30, 2025, indicates continued strong performance. The company maintains a positive outlook, expecting adjusted operating profit to be in line or slightly ahead of expectations for the year ending December 31, 2025. The Group's gross cash stood at £77.6 million, with net funds of £66.0 million after a dividend payment of £3.6 million in July and a £2.5 million tax instalment related to a prior £24.0 million exceptional pre-tax gain. Additionally, Science Group returned £4.4 million to shareholders through its share buy-back program year-to-date. The recovery in R&D services, particularly in the Medical sector, is progressing as anticipated.
Select text to share a quote on X · sign in to keep highlights & notes in your SAG notes
Science Group, the international Professional Services and Systems company delivering innovation through the application of science, technology and engineering, provides a trading update for the 9 months ended 30 September 2025.
Science Group released its Interim Results on 28 July 2025 reporting another period of record Adjusted Operating Profit ("AOP"), despite the unpredictable market environment. In addition, the Group realised a substantial exceptional pre-tax gain (£24.0 million) and associated cash inflow resulting from the H1 strategic investment.
While business confidence remains subdued in some sectors, in aggregate Science Group has continued to perform as anticipated. In particular, the recovery in R&D services, driven by the Medical sector, is progressing as expected.
At 30 September 2025, the Group had gross cash of £77.6 million and net funds of £66.0 million, after payment of the dividend in July (£3.6 million) and the first instalment (£2.5 million) of tax due on the H1 strategic investment gain. In addition, in the year to date, the Company has returned £4.4 million to shareholders through its share buy-back programme.
In summary, despite the volatile market conditions, Science Group remains on track to deliver another strong performance for the year ending 31 December 2025 with AOP in line or slightly ahead of the Board's expectations.
For further information: Science Group plc Martyn Ratcliffe, Executive Chairman Jon Brett, Finance Director Tel: +44 (0) 1223 875 200 www.sciencegroup.com Panmure Liberum (Nomad & Broker) Nicholas How, Max Jones, John More Tel : +44 (0) 20 3100 2000
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.